Ongoing NCI-Funded Clinical Trials Actively Recruiting Patients With Hematologic Cancers: Multiple Myeloma


Get Permission

Study Type: Non-Randomized Phase I/Interventional

Study Title: Multicenter Phase I Study of Th1/Tc1 Immunotherapy Following Autologous Hematopoietic Progenitor Cell Transplantation in High-Risk Multiple Myeloma

Study Sponsor and Collaborators: National Cancer Institute; Hackensack University Medical Center

Purpose: To determine the safety and effectiveness of the infusion of modified Th1 white blood cells, in conjunction with standard treatment, as a treatment for individuals who have been diagnosed with high-risk forms of multiple myeloma.

Ages Eligible for Study: 18 years and older

Genders Eligible for Study: Both

Accepts Healthy Volunteers: No

Primary Outcome Measures: To evaluate the feasibility and toxicity of an infusion of autologous, ex vivo rapamycin-generated, anti-CD3 and anti-CD28 co-stimulated, Th1/Tc1 lymphocytes in subjects with newly diagnosed high-risk multiple ­myeloma.

Principal Investigator: Daniel H. Fowler, MD, National Cancer ­Institute

For More Information: Visit ClinicalTrials.gov and refer to this study by its identifier: NCT01239368

Study Type: Observational
[Patient Registry]

Study Title: Buckeye Surveillance, Contact, and Research for Multiple Myeloma and Amyloidosis

Study Sponsor and Collaborators: Ohio State University Comprehensive Cancer Center

Purpose: To improve the quality and length of life for patients with diseases of their plasma cells

Ages Eligible for Study: 18 years and older

Genders Eligible for Study: Both

Accepts Healthy Volunteers: No

Primary Outcome Measures: Develop a data and sample resource that can be used to facilitate research with the ultimate goal of reducing the morbidity and/or mortality of patients diagnosed or living with multiply myeloma in the state of Ohio

Principal Investigator: Craig Hofmeister

 For More Information: Visit ClinicalTrials.gov and refer to this study by its identifier: NCT01408225


Advertisement

Advertisement



;
Advertisement

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.